These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 10981484)

  • 21. Effects of percutaneous ethanol injection therapy on subsequent parathyroidectomy.
    Chen HH; Hsu MT; Wu CJ; Chen YW; Yang TL
    Am J Surg; 2008 Aug; 196(2):155-9. PubMed ID: 18513687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Intravenous calcitriol in the treatment of the refractory secondary hyperparathyroidism of terminal chronic kidney failure].
    Almirall J; Torregrosa V; Arrizabalaga P; Cases A; Oliva J
    Med Clin (Barc); 1994 Mar; 102(9):325-8. PubMed ID: 8164458
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cinacalcet: An oral calcimimetic agent for the management of hyperparathyroidism.
    Dong BJ
    Clin Ther; 2005 Nov; 27(11):1725-51. PubMed ID: 16368445
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the effects of daily and intermittent-dose calcitriol on serum parathyroid hormone and ionized calcium concentrations in normal cats and cats with chronic renal failure.
    Hostutler RA; DiBartola SP; Chew DJ; Nagode LA; Schenck PA; Rajala-Schultz PJ; Drost WT
    J Vet Intern Med; 2006; 20(6):1307-13. PubMed ID: 17186842
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcomes of secondary hyperparathyroidism in chronic kidney disease and the direct costs of treatment.
    Joy MS; Karagiannis PC; Peyerl FW
    J Manag Care Pharm; 2007 Jun; 13(5):397-411. PubMed ID: 17605511
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A practical self-made device in parathyroid autotransplantation for patients with secondary hyperparathyroidism.
    Du L; Zhang X; Yan L; Zhang H; Tang X; Kong X; Liu G; Huang J
    J Int Med Res; 2019 Jan; 47(1):59-65. PubMed ID: 30198369
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tertiary hyperparathyroidism attributable to long-term oral phosphate therapy.
    McHenry CR; Mostafavi K; Murphy TA
    Endocr Pract; 2006; 12(3):294-8. PubMed ID: 16772203
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The importance of dietary calcium and phosphorous in the secondary hyperparathyroidism of patients with early renal failure.
    Martinez I; Saracho R; Montenegro J; Llach F
    Am J Kidney Dis; 1997 Apr; 29(4):496-502. PubMed ID: 9100037
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination therapy of intravenous maxacalcitol and percutaneous ethanol injection therapy lowers serum parathyroid hormone level and calcium x phosphorus product in secondary hyperparathyroidism.
    Tanaka M; Itoh K; Matsushita K; Matsushita K; Fukagawa M
    Nephron Clin Pract; 2006; 102(1):c1-7. PubMed ID: 16166800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Refractory renal hyperparathyroidism: clinical features and outcome of surgical therapy.
    McHenry CR; Wilhelm SM; Ricanati E
    Am Surg; 2001 Apr; 67(4):310-6; discussion 316-7. PubMed ID: 11307995
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predicting postoperative total calcium requirements after parathyroidectomy in secondary hyperparathyroidism.
    Kang BH; Hwang SY; Kim JY; Hong YA; Jung MY; Lee EA; Lee JE; Lee JB; Ko GJ; Pyo HJ; Kwon YJ
    Korean J Intern Med; 2015 Nov; 30(6):856-64. PubMed ID: 26552461
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomized trial comparing pulse calcitriol and alfacalcidol for the treatment of secondary hyperparathyroidism in haemodialysis patients.
    Kiattisunthorn K; Wutyam K; Indranoi A; Vasuvattakul S
    Nephrology (Carlton); 2011 Mar; 16(3):277-84. PubMed ID: 21342321
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intermittent calcitriol therapy in secondary hyperparathyroidism: a comparison between oral and intraperitoneal administration.
    Salusky IB; Kuizon BD; Belin TR; Ramirez JA; Gales B; Segre GV; Goodman WG
    Kidney Int; 1998 Sep; 54(3):907-14. PubMed ID: 9734615
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 'Pulse oral' versus intravenous calcitriol therapy in chronic hemodialysis patients. A prospective and randomized study.
    Bacchini G; Fabrizi F; Pontoriero G; Marcelli D; Di Filippo S; Locatelli F
    Nephron; 1997; 77(3):267-72. PubMed ID: 9375818
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effects of high dose pulse oral calcitriol on secondary hyperparathyroidism in patients with end-stage renal disease].
    Yang J; Luo N; Liang J
    Zhonghua Nei Ke Za Zhi; 1996 Feb; 35(2):89-91. PubMed ID: 9275624
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of oral falecalcitriol and intravenous calcitriol in hemodialysis patients with secondary hyperparathyroidism: a randomized, crossover trial.
    Ito H; Ogata H; Yamamoto M; Takahashi K; Shishido K; Takahashi J; Taguchi S; Kinugasa E
    Clin Nephrol; 2009 Jun; 71(6):660-8. PubMed ID: 19473635
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypoparathyroidism associated with severe mineral bone disease postrenal transplantation, treated successfully with recombinant PTH.
    Mahajan A; Narayanan M; Jaffers G; Concepcion L
    Hemodial Int; 2009 Oct; 13(4):547-50. PubMed ID: 19493022
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Calcitriol administration in end-stage renal disease: intravenous or oral?
    Quarles LD; Indridason OS
    Pediatr Nephrol; 1996 Jun; 10(3):331-6. PubMed ID: 8792399
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of intravenous calcitriol on platelet intracellular calcium in uremic hemodialysis patients with secondary hyperparathyroidism.
    Lin SH; Shieh SD; Chyr SH; Lu KC; Lin YF; Diang LK; Chou TC; Ding YA
    Zhonghua Yi Xue Za Zhi (Taipei); 1994 Oct; 54(4):240-5. PubMed ID: 7982134
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Randomized controlled trial to compare the efficacy and safety of oral paricalcitol with oral calcitriol in dialysis patients with secondary hyperparathyroidism.
    Ong LM; Narayanan P; Goh HK; Manocha AB; Ghazali A; Omar M; Mohamad S; Goh BL; Shah S; Seman MR; Vaithilingam I; Ghazalli R; Rahmat K; Shaariah W; Ching CH;
    Nephrology (Carlton); 2013 Mar; 18(3):194-200. PubMed ID: 23311404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.